← Leaderboards
Asher A Chanan-Khan
Roswell Park Cancer Institute Corp
$1,374,239
Attributed
$2,588,566
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $610.2K · FY2019–22$1M$750K$500K$250K$0
'19
'20
'21
'22
Funding mix
By agency
NIH$2,588,566 · 2
By mechanism
R01$2,428,654 · 1
R21$159,912 · 1
Top collaborators
- Eduardo N Chini4 shared
Most similar at Roswell Park Cancer Institute Corp
Same institution · by research overlap
- Barbara A Foster$3,566,345
- Young-Mee Park$3,108,922
- Nithya Ramnath$1,296,527
- Zhihong Gong$2,618,766
- Xuefang Cao$8,586,764
Others in their field
Top investigators on “Activities Of Daily Living”
- Marco Pahor · Wake Forest University Health Sciences$72,417,073
- Arie Kapteyn · Rand Corporation$56,708,939
- Jerri Edwards · University Of South Florida$43,630,746
- Jane S Paulsen · University Of Wisconsin-Madison$32,690,665
- Peter J. Snyder · University Of Pennsylvania$32,402,680
- Daniel P Siewiorek · Carnegie Mellon University$29,560,916
Research focus
Activities Of Daily LivingAffinityAggressive Clinical CourseAffectApoptosisApplications GrantsArchitectureBaseAntitumor ResponseBindingBiochemicalBiologicalBiologyB-Lymphocyte CancerB-LymphocytesCancer CellCategoriesCd8b1 GeneCd8-Positive T-LymphocytesCell GrowthCell KillingCell PhysiologyCellsCell Surface Receptors
Grant awards (5)
Therapeutic implication of CD38 in CLL$598,011
R01 · FY2022 · CA · contact PI
Therapeutic implication of CD38 in CLL$610,215
R01 · FY2021 · CA · contact PI
Therapeutic implication of CD38 in CLL$610,215
R01 · FY2020 · CA · contact PI
Therapeutic implication of CD38 in CLL$610,213
R01 · FY2019 · CA · contact PI
VACCINE FOR PATIENTS WITH NON HODGKINS LYMPHOMA$159,912
R21 · FY2001 · CA